Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2023-03-27 00:00:00 ET · period of report 2023-03-24 · accession 0001209191-23-021262 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-27 | 2023-03-24 | CPIX | Krogulski Kenneth | Dir | A - Grant | $1.97 | +5,000 | 210.0K | +2% | +$9,850 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-24 | A | A | 5,000 | $1.97 | 209,955 | D | — | — | (F1) Restricted stock award will vest 100% on March 24, 2024. |